Clinical Trial Detail

NCT ID NCT03074318
Title Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

liposarcoma

leiomyosarcoma

Therapies

Avelumab + Trabectedin

Age Groups: adult senior

No variant requirements are available.